What is a stock summary page? Click here for an overview.
Business Description
D. Western Therapeutics Institute Inc
ISIN : JP3548740004
Description
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.41 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 1.09 | |||||
| Debt-to-EBITDA | -0.73 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -0.89 | |||||
| Beneish M-Score | -2.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.7 | |||||
| 3-Year EBITDA Growth Rate | -110.8 | |||||
| 3-Year EPS without NRI Growth Rate | -91 | |||||
| 3-Year FCF Growth Rate | -82.7 | |||||
| 3-Year Book Growth Rate | -36.3 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.03 | |||||
| 9-Day RSI | 33.12 | |||||
| 14-Day RSI | 37.94 | |||||
| 3-1 Month Momentum % | -40.8 | |||||
| 6-1 Month Momentum % | 60.81 | |||||
| 12-1 Month Momentum % | -7.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.12 | |||||
| Quick Ratio | 10.35 | |||||
| Cash Ratio | 8.49 | |||||
| Days Inventory | 852.02 | |||||
| Days Sales Outstanding | 101.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.3 | |||||
| Shareholder Yield % | -18.73 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 91.27 | |||||
| Operating Margin % | -213.29 | |||||
| Net Margin % | -233.77 | |||||
| FCF Margin % | -282.06 | |||||
| ROE % | -113.38 | |||||
| ROA % | -52.77 | |||||
| ROIC % | -190.01 | |||||
| 3-Year ROIIC % | 3066.44 | |||||
| ROC (Joel Greenblatt) % | -362.05 | |||||
| ROCE % | -56.94 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.47 | |||||
| PB Ratio | 6.07 | |||||
| Price-to-Tangible-Book | 6.46 | |||||
| EV-to-EBIT | -3.79 | |||||
| EV-to-EBITDA | -3.79 | |||||
| EV-to-Revenue | 8.89 | |||||
| EV-to-FCF | -3.12 | |||||
| Price-to-GF-Value | 0.59 | |||||
| Price-to-Median-PS-Value | 0.66 | |||||
| Price-to-Net-Current-Asset-Value | 8.25 | |||||
| Price-to-Net-Cash | 23.36 | |||||
| Earnings Yield (Greenblatt) % | -26.4 | |||||
| FCF Yield % | -29.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
D. Western Therapeutics Institute Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 464.176 | ||
| EPS (TTM) (円) | -33.82 | ||
| Beta | 1.25 | ||
| 3-Year Sharpe Ratio | 0.07 | ||
| 3-Year Sortino Ratio | 0.16 | ||
| Volatility % | 127.35 | ||
| 14-Day RSI | 37.94 | ||
| 14-Day ATR (円) | 7.222251 | ||
| 20-Day SMA (円) | 114.7 | ||
| 12-1 Month Momentum % | -7.03 | ||
| 52-Week Range (円) | 60 - 254 | ||
| Shares Outstanding (Mil) | 41.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
D. Western Therapeutics Institute Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
D. Western Therapeutics Institute Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
D. Western Therapeutics Institute Inc Frequently Asked Questions
What is D. Western Therapeutics Institute Inc(TSE:4576)'s stock price today?
The current price of TSE:4576 is 円107.00. The 52 week high of TSE:4576 is 円254.00 and 52 week low is 円60.00.
When is next earnings date of D. Western Therapeutics Institute Inc(TSE:4576)?
The next earnings date of D. Western Therapeutics Institute Inc(TSE:4576) is .
Does D. Western Therapeutics Institute Inc(TSE:4576) pay dividends? If so, how much?
D. Western Therapeutics Institute Inc(TSE:4576) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers